Release of transforming growth factor beta-1 in a vestibular schwannoma cell line

• Published in: Acta oto-laryngologica Vol. 122; no. 7; pp. 785 - 787
• Main Authors: BIZZARRI, Mariano, FILIPO, Roberto, GRAZIA VALENTE, Maria, BERNARDESCHI, Daniele, RONCHETTI, Francesco, MONINI, Simonetta, CHIAPPINI, Ilaria, BARBARA, Maurizio
• Format: Journal Article
• Language: English
• Published: Stockholm Taylor and Francis 01.10.2002
• Subjects: Antigen-Antibody Complex - blood; Biological and medical sciences; Cell Movement - physiology; Cell Transformation, Neoplastic - secretion; Culture Techniques; Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology; Enzyme-Linked Immunosorbent Assay; Humans; Medical sciences; Neuroma, Acoustic - pathology; Neuroma, Acoustic - secretion; Otorhinolaryngology. Stomatology; Time Factors; Transforming Growth Factor beta - blood; Transforming Growth Factor beta - secretion; Transforming Growth Factor beta1; Tumors; Cell culture; Nervous system diseases; Pathophysiology; Transforming growth factor; Cytokine; Neurinoma; Experimental study; Auditory nerve; Cranial nerve disease; Polypeptide; growth transforming growth factor beta-1; ENT disease; Benign neoplasm; Transforming growth factor β1; Release; vestibular schwannoma; Growth factor
• ISSN: 0001-6489; 1651-2251
• DOI: 10.1080/003655402/000028049

Vestibular schwannoma (VS) often displays an irregular growth pattern due to factors which remain unknown. In this study, VS cell lines from tissue removed during surgery were cultured in order to assess the presence of transforming growth factor beta-1 (TGFbeta-1) a multifunctional polypeptide that has different pleiotropic effects on various tissues. The antibody-binding inhibition assay technique was used. The proliferation rate of VS cell lines in vitro was assessed by [3H]thymidine incorporation, with determinations carried out on days 0, 1, 2 and 4 after removal of fetal calf serum (FCS) from the medium. After 48 h of FCS deprivation, cell growth decreased. TGFbeta-1 release also decreased progressively 24 h after removing FCS from the medium, reaching an overall decrease of 50% after 3 days. The cell culturing procedure appeared suitable for VS cells, in that VS cultures were viable for at least 4 months. TGFbeta-1 was initially shown to be released in significant amounts, but also to decrease progressively to values five times lower after 4 days. These data thus support the possibility of a significant association between TGFbeta-1 release and VS cell replication.